reviewAnnals of OncologyJan 18, 2007Closed access

Trastuzumab: mechanism of action, resistance and future perspectives in HER2-overexpressing breast cancer

GVGiorgio ValabregaFMFilippo MontemurroMAMassimo Aglietta

Candiolo Cancer Institute

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

630
total citations
FWCI
17.63
Percentile
100%
References
77
Citations per year

Authors

3

Topics & keywords

Topics
Keywords
  • Trastuzumab
  • Medicine
  • Breast cancer
  • Acquired resistance
  • Mechanism of action
  • Mechanism (biology)
  • Oncology
  • Pertuzumab
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.